NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 23 04:00PM ET
0.9510
Dollar change
+0.0113
Percentage change
1.20
%
Index- P/E- EPS (ttm)-5.80 Insider Own0.84% Shs Outstand14.13M Perf Week1.17%
Market Cap13.44M Forward P/E- EPS next Y-1.74 Insider Trans0.00% Shs Float14.01M Perf Month-14.32%
Income-23.23M PEG- EPS next Q-0.42 Inst Own10.46% Short Float5.18% Perf Quarter-11.12%
Sales0.00M P/S- EPS this Y71.73% Inst Trans1.15% Short Ratio0.52 Perf Half Y-63.63%
Book/sh0.00 P/B320.20 EPS next Y2.61% ROA-89.59% Short Interest0.73M Perf Year-80.83%
Cash/sh0.55 P/C1.74 EPS next 5Y37.34% ROE-214.79% 52W Range0.40 - 5.15 Perf YTD-44.06%
Dividend Est.- P/FCF- EPS past 5Y26.36% ROI-6312.23% 52W High-81.53% Beta1.61
Dividend TTM- Quick Ratio1.35 Sales past 5Y0.00% Gross Margin- 52W Low139.25% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.35 EPS Y/Y TTM55.36% Oper. Margin- RSI (14)46.00 Volatility1.79% 4.07%
Employees17 Debt/Eq11.25 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price10.67
Option/ShortNo / Yes LT Debt/Eq8.25 EPS Q/Q65.82% Payout- Rel Volume0.07 Prev Close0.94
Sales Surprise- EPS Surprise-24.32% Sales Q/Q- EarningsMay 13 AMC Avg Volume1.40M Price0.95
SMA20-5.16% SMA50-3.10% SMA200-47.87% Trades Volume103,653 Change1.20%
Date Action Analyst Rating Change Price Target Change
Feb-12-25Downgrade Maxim Group Buy → Hold
Jul-18-22Resumed Oppenheimer Outperform $14
May-15-25 03:12AM
May-14-25 07:30AM
May-13-25 05:19AM
May-12-25 08:40AM
May-07-25 09:00AM
09:00AM Loading…
May-06-25 09:00AM
May-05-25 08:45AM
Apr-29-25 08:35AM
Apr-17-25 08:30AM
Apr-02-25 08:41AM
05:51AM
Apr-01-25 09:55AM
08:30AM
Mar-26-25 12:00PM
Mar-25-25 03:00AM
01:38AM Loading…
01:38AM
Mar-24-25 10:50AM
07:05AM
Mar-19-25 08:05AM
Mar-11-25 08:45AM
Mar-10-25 08:45AM
Mar-06-25 08:30AM
Mar-03-25 08:30AM
Feb-25-25 12:35PM
Feb-13-25 01:19PM
01:05PM
09:25AM
Feb-12-25 10:25AM
Feb-11-25 08:40AM
Jan-27-25 08:30AM
08:30AM Loading…
Jan-08-25 08:30AM
08:30AM
Dec-11-24 08:00AM
Nov-18-24 08:15AM
Nov-14-24 08:15AM
Nov-12-24 10:59PM
08:00AM
Nov-11-24 11:19PM
07:05AM
Nov-05-24 09:00AM
Nov-04-24 08:30AM
Oct-18-24 08:57AM
Oct-17-24 08:40AM
Oct-09-24 05:02PM
Oct-07-24 08:30AM
Oct-04-24 09:00AM
Sep-23-24 08:00AM
Sep-16-24 08:30AM
Sep-09-24 08:15AM
Sep-03-24 09:15AM
Aug-26-24 08:30AM
Aug-19-24 04:05PM
Aug-16-24 08:00AM
Aug-14-24 08:05AM
Aug-05-24 09:05AM
Aug-01-24 08:30AM
Jul-10-24 08:30AM
Jun-17-24 08:00AM
Jun-14-24 08:00AM
Jun-12-24 09:00AM
Jun-10-24 08:00AM
Jun-05-24 08:55AM
May-16-24 08:32AM
06:22AM
May-15-24 08:38AM
May-14-24 03:00AM
May-13-24 07:30AM
May-10-24 09:52PM
May-09-24 08:30AM
May-08-24 08:45AM
May-07-24 08:55AM
May-02-24 09:00AM
May-01-24 08:50AM
Apr-25-24 09:45AM
Apr-18-24 08:30AM
Apr-10-24 08:30AM
Mar-28-24 10:45AM
Mar-27-24 09:25AM
09:05AM
Mar-26-24 08:36AM
Mar-25-24 07:30AM
Mar-22-24 08:52PM
05:31PM
04:05PM
Mar-20-24 07:30AM
Mar-19-24 04:30PM
Mar-12-24 09:05AM
Jan-24-24 08:50AM
Dec-20-23 09:16PM
Dec-11-23 08:50AM
Nov-14-23 01:46PM
10:29AM
Nov-13-23 08:05AM
08:00AM
Nov-07-23 08:45AM
Nov-06-23 08:35AM
Oct-24-23 07:45AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Oct-02-23 08:40AM
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.